Investing

Acorda Therapeutics Inc : ACOR

ACOR

Stock Data

$0.00

$0.00 (0.00%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and markets therapies for neurological disorders in the United States. The company is headquartered in Ardsley, New York.

All ACOR Articles

42 Articles

Chris Lange | Jun 17, 2021 at 9:14 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Altice, Altria, Ambev, Camping World, Charter Communications, Coca-Cola and More

Thursday’s top analyst upgrades and downgrades included Altria, Bill.com, Boot Barn, Camping World, Charter Communications, Coca-Cola and Jack in the…

Lee Jackson | Oct 24, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: BankUnited, Caterpillar, CoreLogic, eBay, Ford, Kellogg, Lyft, Microsoft, Oshkosh and More

Thursday's top analyst upgrades, downgrades and initiations included BankUnited, Caterpillar, Costco, eBay, Ford, Kellogg, Lyft, Microsoft and Oshkosh.

Jon C. Ogg | Aug 14, 2019 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: Acorda, Activision, Bloom Energy, Care.com, CBS, Deere, Ferrari and More

The top analyst upgrades, downgrades and initiations for Wednesday included Acorda Therapeutics, Activision Blizzard, Bloom Energy, Care.com, CBS, Deere and…

Jon C. Ogg | Oct 5, 2018 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo, Roku and More

The top analyst upgrades, downgrades and initiations seen on Friday included Carbonite, Cleveland-Cliffs, Conoco, Costco, EA, Eli Lilly, HP, PepsiCo…

Chris Lange | Sep 13, 2018 at 11:20 AM EDT

Can Acorda Therapeutics Get Past This FDA Move?

Acorda Therapeutics shares dipped on Thursday after the company announced that the FDA would be delaying its Prescription Drug User…

Jon C. Ogg | Feb 16, 2018 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: Alarm.com, Biogen, Blue Apron, Cisco, Lowe’s, Pandora, Waste Management and More

The top analyst upgrades, downgrades and other research calls from Friday include Alarm.com, Biogen, Blue Apron, Cisco, Lowe's, Pandora Media…

Chris Lange | Dec 28, 2017 at 11:50 AM EST

Top 10 Biopharma Events Kicking Off 2018

Jefferies has put together a list of 10 biotech companies that could have developments coming up in the next two…

Jon C. Ogg | Nov 16, 2017 at 9:05 AM EST

Top Analyst Upgrades and Downgrades: Cisco, Dollar General, NetApp, Pandora, P&G, Target and More

The top analyst upgrades, downgrades and other research calls from Thursday include Cisco Systems, Dollar General, NetApp, Pandora Media, Procter…

Chris Lange | Nov 15, 2017 at 8:45 AM EST

Acorda Therapeutics Gets Crushed After Halting Parkinson’s Trial

Acorda Therapeutics saw its shares drop sharply following an announcement that it had paused new enrollment in a long-term safety…

Jon C. Ogg | Nov 8, 2017 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Equifax, Mallinckrodt, Nabors, Qualcomm, Salesforce, Snap and More

The top analyst upgrades, downgrades and other research calls from Wednesday include Equifax, Mallinckrodt, Nabors, Qualcomm, Salesforce and Snap.

Chris Lange | Aug 29, 2017 at 9:50 AM EDT

Acorda Therapeutics Shares Crushed After Receipt of FDA Refusal Letter

Acorda Therapeutics saw its shares get crushed early on Tuesday after the firm received a Refusal to File letter from…

Jon C. Ogg | Mar 13, 2017 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: AIG, Boeing, GameStop, Gilead, Starbucks, CIGNA, Ciena, Ferrari and Many More

The top analyst upgrades, downgrades and initiations seen on Monday include AIG, Boeing, GameStop, Gilead Sciences, Starbucks, CIGNA, Ciena and…

Jon C. Ogg | Feb 15, 2017 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: BBVA, Fossil, P&G, T-Mobile, Under Armour, Universal Display and Many More

The top analyst upgrades, downgrades and initiations seen on Wednesday include BBVA, Fossil, Procter & Gamble, T-Mobile, Under Armour and…

Chris Lange | Feb 9, 2017 at 10:25 AM EST

Is This the Big Turnaround Acorda Needs?

Shares of Acorda Therapeutics saw a hand gain in early trading on Thursday after the company reported results from its…

Lee Jackson | Dec 19, 2016 at 8:55 AM EST

Top Analysts Upgrades and Downgrades: Anadarko Petroleum, Bristol-Myers, Comcast, Disney, Merck and More

Monday’s top analyst upgrades, downgrades and initiations include Anadarko Petroleum, Bristol-Myers Squibb, Comcast, Walt Disney and Merck.